相关实验视频

Updated: Jun 10, 2025

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

阴影和灯光在败血症免疫疗法中

Guillaume Monneret^1,2, Muzhda Haem Rahimi^1,2, Anne-Claire Lukaszewicz^2,3

¹Hospices Civils de Lyon, Immunology Laboratory, Hôpital E. Herriot, Lyon, France.

Expert opinion on pharmacotherapy

|October 17, 2024

概括

败血症治疗正在转向精准医学. 生物标志物将有助于个性化免疫疗法,通过根据个体免疫炎症反应量身定制治疗来改善患者的治疗结果.

科学领域:

免疫学和重症监护医学.
在败血症管理的翻译性研究.

背景情况:

败血症对全球健康造成重大负担.
主体反应涉及复杂的炎症和免疫抑制机制.
以前的"适合所有人"的抗炎疗法表现出有限的成功.

研究的目的:

要突出毒症管理向精准医学的演变.
用生物标志物强调患者分层的重要性.
讨论多组学在定义免疫-炎症轨迹中的作用.

主要方法:

审查目前对败血症病理生理学的理解.
讨论新兴的精准医学策略.
在临床实践和研究中探索生物标志物的实用性.

主要成果:

精准医学为免疫疗法 (抗炎或免疫刺激) 提供了个性化的方法.
基于生物标志物的患者分层对于即将进行的临床试验至关重要.
预计转录组学和多组学的标准化使用将增强生物标志物发现.

结论:

个性化免疫疗法有望改善败血症的结果.
生物标志物驱动的分层是促进败血症治疗的关键.
多omics技术的整合将改进患者管理策略.

关键词:

败血症这是一种败血症.免疫抑制是一种免疫抑制.免疫疗法免疫疗法这是一种炎症炎症炎症炎症.在 mHLA-DR 中使用.败血症的冲击是一个令人震惊的现象.

更多相关视频

A Data-Driven Approach to Quantifying Immune States in Sepsis

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

Published on: November 6, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.